Low Testosterone and Erectile Dysfunction: The Hidden Connection Most Men Miss

When men experience erectile dysfunction, the conversation quickly turns to blood flow, stress, or relationship dynamics. But for a significant subset — possibly one in three — the underlying driver is something far more fundamental: low testosterone. Understanding how low testosterone causes erectile dysfunction may be the missing piece that finally explains why other approaches haven't worked.

This article walks through the physiology, the clinical evidence, and what it means practically for men navigating ED today.

What Is Testosterone's Role in Erection Biology?

Testosterone isn't just the hormone behind libido and muscle mass. It plays a direct, mechanistic role in erectile function at the tissue level.

Erections depend on the nitric oxide–cyclic GMP (NO-cGMP) signaling pathway. When sexual arousal occurs, nitric oxide is released in the penile smooth muscle, triggering relaxation of the corpus cavernosum and increased blood inflow. Testosterone is required for the normal expression of nitric oxide synthase (NOS) — the enzyme that initiates this cascade.

In men with low testosterone, NOS activity is blunted. The signaling pathway is essentially running on low fuel. Research published in the American Journal of Medicine showed that smooth muscle relaxation in the corpus cavernosum was markedly impaired in hypogonadal subjects — and normalized following testosterone replacement. This puts testosterone at the very beginning of the erection pathway, not just as a background hormone.

Beyond the biochemistry, testosterone also maintains the structural integrity of penile tissue. Chronic androgen deficiency is associated with increased fibrosis in the corpora cavernosa — essentially scarring that reduces the organ's mechanical ability to achieve and maintain full engorgement.

How Common Is Low Testosterone in Men With ED?

The overlap between hypogonadism and ED is substantial, and often underdiagnosed.

A 2025 consensus document from the Fifth International Consultation on Sexual Medicine (ICSM 2024), published in Sexual Medicine Reviews, concluded that routine morning testosterone testing should be offered to all men presenting with erectile dysfunction — not just those with obvious symptoms of low T. Their rationale: testosterone deficiency frequently co-exists with ED in ways that are clinically silent outside of the sexual domain, and treating it can meaningfully improve outcomes that PDE5 inhibitors alone cannot fully address.

A 2025 review in MDPI Diagnostics noted that both primary hypogonadism (testicular failure) and secondary hypogonadism (pituitary/hypothalamic dysfunction) reliably produce testosterone deficiency and ED, and that age-related testosterone decline — well-documented after 35 — significantly compounds this risk. Testosterone levels decline at approximately 1–2% per year from the mid-30s onward, meaning that by their 50s, many men are operating with testosterone levels 20–30% below their peak.

The clinical implication: if you have ED and you haven't had your testosterone checked, you may be treating the symptom while ignoring the cause.

When PDE5 Inhibitors Alone Aren't Enough

Phosphodiesterase-5 inhibitors (PDE5 inhibitors) — including tadalafil, vardenafil, and sildenafil — remain the first-line pharmacological treatment for ED, and they're highly effective. But a subset of men don't respond well to them, and testosterone deficiency may explain why.

A systematic review and meta-analysis published in PMC examined whether testosterone supplementation enhances the response to PDE5 inhibitors in hypogonadal men with ED. The findings were clear: men receiving both testosterone and PDE5 inhibitors showed an improvement of 4.4 IIEF (International Index of Erectile Function) points from baseline, compared to just 2.1 points with monotherapy (p=0.029). The combination therapy was also reported as effective and safe across the studies reviewed.

The mechanism makes sense physiologically: PDE5 inhibitors work downstream in the NO-cGMP pathway. But if testosterone deficiency has suppressed NOS expression and reduced nitric oxide production at the upstream level, there's simply less signal for the PDE5 inhibitor to amplify. Restoring testosterone helps prime the system so that PDE5 inhibition can do its job.

For men who've tried PDE5 inhibitors without satisfying results, a testosterone evaluation is a clinically rational next step.

Signs That Low Testosterone May Be Contributing to Your ED

Low testosterone doesn't always announce itself with obvious symptoms. Many men with clinically low T feel "generally fine" but report a cluster of subtle changes over time:

• Reduced morning erections or erections that feel less firm
• Decreased spontaneous sexual thoughts or a noticeable drop in sexual interest over months or years
• Fatigue that doesn't resolve with adequate sleep — especially mid-afternoon energy crashes
• Reduced muscle mass or difficulty maintaining body composition despite consistent training
• Mood changes — increased irritability, low-grade low mood, or reduced motivation
• Difficulty concentrating or brain fog

None of these symptoms alone confirms low testosterone, and they overlap with other conditions including sleep apnea, hypothyroidism, and depression. But in combination with ED, they make a strong clinical case for checking morning testosterone levels.

The diagnostic threshold matters: total testosterone below 300 ng/dL is the widely used clinical cutoff for hypogonadism, though some men experience symptoms at levels between 300–400 ng/dL, particularly if sex hormone-binding globulin (SHBG) is elevated — which reduces the amount of biologically available (free) testosterone.

The Lifestyle–Testosterone Connection

Testosterone is a hormone that responds directly to lifestyle inputs — more so than most men realize. Several modifiable behaviors significantly suppress testosterone production:

Excess body fat, particularly visceral adiposity, increases aromatase activity — the enzyme that converts testosterone to estrogen. A higher waist circumference is independently associated with lower testosterone and higher ED risk.

Sleep deprivation is among the most potent suppressors of testosterone. A well-cited study found that just one week of sleeping 5 hours per night reduced daytime testosterone levels by 10–15% in young healthy men.

Chronic psychological stress elevates cortisol, which directly inhibits testosterone synthesis at the hypothalamic-pituitary-gonadal axis level.

Sedentary behavior is associated with lower testosterone, while resistance training — particularly compound lifts — produces acute and chronic testosterone elevations.

Alcohol consumed in excess is directly toxic to Leydig cells, the primary testosterone-producing cells in the testes.

The implication: men with borderline testosterone levels may be able to meaningfully shift their numbers through targeted lifestyle changes. For those with clinically low levels, lifestyle optimization is valuable but often insufficient on its own.

Clinically Formulated Support for Men Who Need It

For men whose ED has a vascular or neurogenic component — rather than purely hormonal — daily low-dose PDE5 inhibitors represent one of the best-studied approaches available. Consistent daily therapy maintains baseline cGMP signaling, supports penile tissue health, and can restore spontaneous erectile function over time.

OnyxMD's EPIQ CHEWS are formulated for exactly this use case: a daily chewable combining Tadalafil 5mg and Vardenafil 5mg for men who want consistent, low-maintenance support. The dual-PDE5-inhibitor approach targets both the PDE5-A and PDE5-B isoforms, and the chewable delivery format offers faster buccal absorption compared to standard oral tablets. Vitamin D3 and K2 are included to support vascular health — relevant given the strong association between vitamin D deficiency, endothelial function, and ED outcomes.

All treatments are prescribed by licensed physicians following a free medical intake. No in-person visit required.

Conclusion: Get the Full Picture Before Treating the Surface

Low testosterone is a medically recognized, treatable condition — and it's far more common in men with ED than routine clinical practice acknowledges. The 2024 ICSM consensus recommendations are clear: testosterone should be part of the workup for any man presenting with erectile dysfunction.

Treating ED effectively often requires understanding whether low testosterone is part of the equation. When it is, addressing it — alone or in combination with PDE5 inhibitor therapy — clinical studies suggest significantly better outcomes than either approach in isolation.

If you're ready to explore clinically-formulated options, OnyxMD offers physician-supervised treatment plans starting with a free online assessment at questionnaire.getonyxmd.com.

---

Explore our full product range or browse more articles on men's health.

---

These statements have not been evaluated by the FDA. This content is for informational purposes only and does not constitute medical advice.